Familial chylomicronemia syndrome: case reports of siblings with deletions of the GPIHBP1 gene

被引:0
作者
Kim, Ka Young [1 ]
Heo, You Joung [2 ]
Ko, Jung Min [3 ]
Lee, Young Ah [3 ]
Shin, Choong Ho [3 ]
Ki, Chang Seok [4 ]
Lee, Yun Jeong [3 ]
机构
[1] Catholic Kwandong Univ, Int St Marys Hosp, Dept Pediat, Incheon, South Korea
[2] Chung Ang Univ, Gwangmyeong Hosp, Dept Pediat, Sch Med, Gwangmyeong, South Korea
[3] Seoul Natl Univ, Childrens Hosp, Dept Pediat, Seoul, South Korea
[4] GC Genome, Yongin, South Korea
关键词
Hyperlipoproteinemias; Chylomicrons; Hypertriglyceridemia; TYPE-1; HYPERLIPOPROTEINEMIA; LIPOPROTEIN-LIPASE; CURRENT DIAGNOSIS; MANAGEMENT; INFANT;
D O I
10.1186/s12902-024-01574-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Familial chylomicronemia syndrome (FCS) is a rare monogenic form of severe hypertriglyceridemia, caused by mutations in genes involved in triglyceride metabolism. Herein, we report the case of a Korean family with familial chylomicronemia syndrome caused by compound heterozygous deletions of glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPIHBP1). Case presentation A 4-year-old boy was referred for the evaluation of severe hypertriglyceridemia (3734 mg/dL) that was incidentally detected 4 months prior. His elder brother also demonstrated an elevated triglyceride level of 2133 mg/dL at the age of 9. Lipoprotein electrophoresis revealed the presence of chylomicrons, an increase in the proportion of pre-beta lipoproteins, and low serum lipoprotein lipase levels. The patient's parents and first elder brother had stable lipid profiles. For suspected FCS, genetic testing was performed using the next-generation sequencing-based analysis of 31 lipid metabolism-associated genes, which revealed no pathogenic variants. However, copy number variant screening using sequencing depth information suggested large heterozygous deletion encompassing all the coding exons of GPIHBP1. A real-time quantitative polymerase chain reaction was performed to validate the deletion site. The results showed that the siblings had two heterozygous copy number variants consisting of the whole gene and an exon 4 deletion, each inherited from their parents. During the follow-up period of 17 months, the patient did not develop pancreatitis, following dietary intervention. Conclusion These siblings' case of familial chylomicronemia syndrome caused by rare GPIHBP1 deletions highlight the implementation of copy number variants-beyond next-generation sequencing-as an important consideration in diagnosis. Accurate genetic diagnosis is necessary to establish the etiology of severe hypertriglyceridemia, which increases the risk of pancreatitis.
引用
收藏
页数:6
相关论文
共 22 条
  • [1] Familial chylomicronemia syndrome and response to medium-chain triglyceride therapy in an infant with novel mutations in GPIHBP1
    Ahmad, Zahid
    Wilson, Don P.
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2014, 8 (06) : 635 - 639
  • [2] [Anonymous], 2015, The Human Gene Mutation Database
  • [3] 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
    Catapano, Alberico L.
    Graham, Ian
    De Backer, Guy
    Wiklund, Olov
    Chapman, M. John
    Drexel, Heinz
    Hoes, Arno W.
    Jennings, Catriona S.
    Landmesser, Ulf
    Pedersen, Terje R.
    Reiner, Zeljko
    Riccardi, Gabriele
    Taskinen, Marja-Riita
    Tokgozoglu, Lale
    Verschuren, W. M. Monique
    Vlachopoulos, Charalambos
    Wood, David A.
    Luis Zamorano, Jose
    [J]. ATHEROSCLEROSIS, 2016, 253 : 281 - 344
  • [4] The role of genetic testing in dyslipidaemia
    Berberich, Amanda J.
    Hegele, Robert A.
    [J]. PATHOLOGY, 2019, 51 (02) : 184 - 192
  • [5] Type 1 hyperlipoproteinemia due to a novel deletion of exons 3 and 4 in the GPIHBP1 gene
    Berge, Knut Erik
    Retterstol, Kjetil
    Romeo, Stefano
    Pirazzi, Carlo
    Leren, Trond P.
    [J]. ATHEROSCLEROSIS, 2014, 234 (01) : 30 - 33
  • [6] Chylomicronaemia-current diagnosis and future therapies
    Brahm, Amanda J.
    Hegele, Robert A.
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2015, 11 (06) : 352 - 362
  • [7] Genotype-phenotype relationships in patients with type I hyperlipoproteinemia
    Chokshi, Neema
    Blumenschein, Sarah D.
    Ahmad, Zahid
    Garg, Abhimanyu
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2014, 8 (03) : 287 - 295
  • [8] Involvement of a homozygous exon 6 deletion of LMF1 gene in intermittent severe hypertriglyceridemia
    Dancer, Marine Serveaux
    Marmontel, Oriane
    Wozny, Anne-Sophie
    Marcais, Christophe
    Mahl, Muriel
    Dumont, Sabrina
    Simonet, Thomas
    Moulin, Philippe
    Di Filippo, Mathilde
    Charriere, Sybil
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2020, 14 (06) : 756 - 761
  • [9] GPIHBP1 Is Responsible for the Entry of Lipoprotein Lipase into Capillaries
    Davies, Brandon S. J.
    Beigneux, Anne P.
    Barnes, Richard H., II
    Tu, Yiping
    Gin, Peter
    Weinstein, Michael M.
    Nobumori, Chika
    Nyren, Rakel
    Goldberg, Ira
    Olivecrona, Gunilla
    Bensadoun, Andre
    Young, Stephen G.
    Fong, Loren G.
    [J]. CELL METABOLISM, 2010, 12 (01) : 42 - 52
  • [10] Genetics of Hypertriglyceridemia
    Dron, Jacqueline S.
    Hegele, Robert A.
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2020, 11